UBS Group
GPAT

UBS Group’s GP-Act III Acquisition Corp GPAT Stock Holding History

UBS Group’s Portfolio GPAT Stock Details GPAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195 Sell
18
-168
-90% -$1.82K ﹤0.01% 10009
2026
Q1 		$2.02K Sell
186
-2,045
-92% -$22K ﹤0.01% 9380
2025
Q4 		$23.8K Sell
2,231
-8,926
-80% -$95.2K ﹤0.01% 7661
2025
Q3 		$118K Buy
11,157
+3,124
+39% +$33K ﹤0.01% 7003
2025
Q2 		$84.7K Buy
8,033
+3,883
+94% +$40.6K ﹤0.01% 7371
2025
Q1 		$42.7K Buy
4,150
+3,750
+938% +$38.4K ﹤0.01% 7699
2024
Q4 		$4.06K Buy
+400
New +$4.04K ﹤0.01% 8794

Other funds holding GPAT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS Group's GPAT Position: Q2 2026 in Review

UBS Group reduced its GP-Act III Acquisition Corp (GPAT) stake by 90% in Q2 2026, selling an estimated $1.82K and leaving 18 shares worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #10009.

UBS Group first reported a position in GPAT in Q4 2024 and has held it in 7 quarters since. The position peaked at $118K in Q3 2025. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • UBS Group held 18 shares of GP-Act III Acquisition Corp worth $195 as of Q2 2026.
  • UBS Group sold 168 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $1.82K.
  • GP-Act III Acquisition Corp made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10009 holding.
  • UBS Group first reported a position in GP-Act III Acquisition Corp in Q4 2024 and has held it in 7 quarters since.
  • UBS Group's GP-Act III Acquisition Corp position peaked at $118K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.